Z-drugs were marketed as a safer, more targeted alternative to benzodiazepines. In practice, many of the same problems remain: anterograde amnesia, complex sleep behaviors including driving and eating while unconscious, dependence risk, and disrupted sleep architecture at higher doses. Z-drugs make up over 40% of sleep prescriptions in the US, with Ambien claiming nearly 90% of that.